National Cancer Institute, FDA Eye Clinical Trial Modernization

NCI’s latest cancer study is straying from the typical approach for testing new treatments in a way that aims to remove common roadblocks to accessing these trials.

The announcement is part of a broader federal effort to modernize clinical trials and is focused on lung cancer, one of the most common cancers in the US.

The National Cancer Institute announced Wednesday that it’s enrolling people for a new clinical trial to see if a treatment consisting of Merck & Co. Inc.‘s Keytruda combined with Eli Lilly & Co.‘s Cyramza improves the survival of patients with advanced non-small cell ...